Percentage of Keyhole Limpet Hemocyanin (KLH) Responders at Day 28 Post-Vaccination [clinicaltrials_resource:NCT00536120/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Percentage of Keyhole Limpet Hemocyanin (KLH) Responders at Day 28 Post-Vaccination [clinicaltrials_resource:NCT00536120/outcome/1]
Bio2RDF identifier
NCT00536120/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00536120/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
Participants who had received ...... easurement at given timepoint.
Participants who had received ...... relevant analysis population.
Participants who received at l ...... easurement at given timepoint.
Participants with an assessmen ...... used in the primary analyses.
Participants with an assessmen ...... used in the primary analyses.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
28 days after immunization (Da ...... sabri Plus Vaccinations Group)
Month 0 (Baseline), Month 3
Month 0 (Baseline), Month 3, and Month 6
Month 0 (Baseline), Month 6
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Keyhole Limpet Hemocyanin (KLH) Responders at Day 28 Post-Vaccination
@en
identifier
clinicaltrials_resource:NCT00536120/outcome/1
title
KLH responders were defined as ...... ys after vaccination with KLH.
@en
type
label
Percentage of Keyhole Limpet H ...... esource:NCT00536120/outcome/1]
@en